Research Initiative for Scientific Enhancement (RISE) (R25)

The summary for the Research Initiative for Scientific Enhancement (RISE) (R25) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Research Initiative for Scientific Enhancement (RISE) (R25): The National Institute of General Medical Sciences (NIGMS) will award Research Initiative for Scientific Enhancement (RISE) research education grants (R25) to institutions focused on developing new or expanding existing effective institutional developmental programs designed to academically and scientifically prepare underrepresented (UR) students in the biomedical or behavioral sciences for competitive research careers. The RISE program provides grants to institutions with significant enrollment of students from populations underrepresented in the biomedical and behavioral sciences that propose well-integrated developmental activities designed to strengthen students academic preparation, research training and professional skills that are critical to the completion of the Ph.D. degree in the biomedical and/or behavioral sciences.

Federal Grant Title:	Research Initiative for Scientific Enhancement (RISE) (R25)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAR-13-196
Type of Funding:	Grant
CFDA Numbers:	93.859
CFDA Descriptions:	Biomedical Research and Research Training
Current Application Deadline:	Jun 20, 2013
Original Application Deadline:	Jun 20, 2013
Posted Date:	Apr 15, 2013
Creation Date:	Apr 15, 2013
Archive Date:	Jul 21, 2013
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Public and State controlled institutions of higher education - Private institutions of higher education - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs) ; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Grant Announcement Contact: NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants: • Undergraduate Research Training Initiative for Student Enhancement (U-RISE) (T34); • Maximizing Access to Research Careers (MARC) (T34); • Medical Scientist Training Program (MSTP) (T32); • Single Source: The NIGMS Human Genetic Cell Repository (U42 - Clinical Trial Not Allowed); • Native American Research Centers for Health (NARCH) Planning Grants (R34 - Clinical Trial ...; • Tools for Genetic and Genomic Studies in Emerging Model Organisms; • Evolution of Infectious Diseases; • Mbrs Support of Continuous Research Excellence (Score)
More Grants from the National Institutes of Health: • Type 1 Diabetes TrialNet Clinical Network Hub (U01 Clinical Trial Not Allowed); • Advancing HIV service delivery through pharmacies and pharmacists (R21 Clinical Trial Opti...; • Advancing HIV service delivery through pharmacies and pharmacists (R01 Clinical Trial Opti...; • Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Required); • Independent Scientist Award (Parent K02 Independent Basic Experimental Studies with Humans...